Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Target

kinase inhibitors

3 abstracts

Abstract
Symptomatic adverse events in lung cancer clinical trials included in US drug labels from 2015 to 2021 to inform patient-reported outcomes.
Org: Oncology Center of Excellence, U.S. Food and Drug Administration, ORISE Fellow, Center for Drug Evaluation and Research, Office of Oncologic Diseases,
Abstract
Survivorship in patients with cardiac metastases defined by cardiac magnetic resonance imaging in relation to lesion hypoperfusion.
Org: Weill Cornell Medical College University, New York, NY, Memorial Sloan Kettering Cancer Center, Sarcoma Medical Oncology Service,
Abstract
Correlations between overall response rate, progression-free survival and overall survival with kinase inhibitors in radioiodine-refractory differentiated thyroid cancers: A systematic review and meta-analysis.
Org: One Brooklyn Health/Brookdale University Hospital and Medical Center, Brooklyn ImmunoTherapeutics, Nykode Therapeutics,